About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- Wall Street bull Ed Yardeni predicts stocks will fly 17% between now and 2021
- 10 low-cost franchises you can start with $15,000 or less and reap a six-figure salary
- 52% of Americans are considered 'middle class'—here's how much money they earn
- Iran responsible for 'attack against the world' after strikes on oil facilities, Saudi official says
- Here's what one top economist sees ahead for the Fed and US-China trade
NBR on TwitterMy Tweets
Subscribe to RSS
Berkeley Lovelace Jr.’s Posts
Steve Miller, chairman of Purdue Pharma’s board of directors, told CNBC on Monday that the OxyContin maker’s bankruptcy and tentative deal to resolve opioid lawsuits was the “only way” to get help to victims of the crisis as quickly as possible.
An Oklahoma judge on Monday ruled against Johnson & Johnson in the Oklahoma opioid trial, forcing the company to pay the state $572 million in the first trial in the U.S. seeking to hold a drugmaker accountable for helping fuel the epidemic.
An Oklahoma judge is expected to issue what will be a landmark ruling Monday on whether Johnson & Johnson will be held responsible for the state’s opioid epidemic that officials say led to more than 6,000 deaths over nearly two decades.
President Donald Trump says the U.S. should begin building more mental health institutions to combat the nation’s ongoing gun violence.
Shares of drug distributors fell Tuesday after a report said McKesson, Cardinal Health and AmerisourceBergen have proposed paying $10 billion to settle claims they helped to fuel the U.S. opioid epidemic.
President Donald Trump on Monday called for reforms to the nation’s mental health laws after back-to-back shootings in El Paso, Texas and Dayton, Ohio over the weekend killed at least 31 people.
The Trump administration outlined on Wednesday a proposal that would allow the U.S. to legally import cheaper prescription drugs from Canada, a tactic the U.S. pharmaceutical industry and regulators have warned could threaten consumer safety.
President Donald Trump is working on a proposal that would allow the United States to import drugs from Canada, Health and Human Services Secretary Alex Azar told CNBC.
Senate Finance Committee Chairman Chuck Grassley said Thursday that he wants to include an abandoned White House proposal that would have eliminated rebates from government drug plans in the final version of a bipartisan drug pricing bill.
The House is scheduled to vote Wednesday on a bill that would scrap Obamacare’s so-called “Cadillac tax,” an inactive provision of the health law meant to help control health-care spending.
Pharmaceutical giant Johnson & Johnson is set to test an experimental HIV vaccine in the U.S. and Europe sometime this year, the company confirmed with CNBC.
House Speaker Nancy Pelosi’s latest draft of legislation allowing Medicare to negotiate lower drug prices would also apply those discounts to private health plans across the U.S., according to a senior Democratic aide.
President Donald Trump will issue Monday an executive order designed to pressure insurers, doctors and other health-care providers to disclose more information about their prices, administration officials said.
A pharmacy warned the Food and Drug Administration that it found a chemical believed to cause cancer in a widely used blood pressure medication, according to a filing from the federal agency.
Patients with private health insurance will soon be able to get HIV prevention medication, also known as pre-exposure prophylaxis or PrEP, at no cost after a recommendation from an influential health-care panel Tuesday.